Pharmaceutical Contract Packaging Global Market Report 2024

The global pharmaceutical contract packaging market has grown strongly in recent years. It will grow from $29.32 billion in 2023 to $31.87 billion in 2024 at a compound annual growth rate (CAGR) of 8.7%. The growth observed in the historic period can be traced back to several key factors, including the escalating complexity of packaging regulations, the pressing demand for swift time-to-market delivery, the need for specialized packaging solutions, the globalization of pharmaceutical supply chains, endeavors aimed at cost savings and operational efficiency, and the imperative for flexible production scale. These elements collectively contributed to the growth witnessed during that period.

The global pharmaceutical contract packaging market is expected to see strong growth in the next few years. It will grow to $43.83 billion in 2028 at a compound annual growth rate (CAGR) of 8.3%. The anticipated growth in the forecast period is primarily driven by an amplified emphasis on sustainable packaging practices, a heightened demand for on-demand packaging services, the unfolding trends in customization and personalization, a rising need for child-resistant packaging solutions, and strategic investments geared towards enhancing packaging infrastructure. Additionally, major trends expected in this period encompass compliance initiatives like serialization and track-and-trace, technological advancements in packaging equipment, specialized innovations in cold chain packaging, tailored adherence packaging to ensure patient compliance, the evolution of personalized medicine packaging, and robust investments in digitalization and industry 4.0 within the packaging landscape.

The pharmaceutical contract packaging market is expected to experience growth due to the increasing number of elderly populations. This demographic, comprising individuals aged 65 and older, demands specialized packaging that is easy to open while maintaining child-resistant features. However, this requirement for specialized packaging can heighten costs and potentially affect sustainability. Projections from the United Nations and the World Health Organization indicate a substantial rise in the elderly population by 2050, from 9.3% in 2020 to an estimated 16.0%. This demographic shift is a key driver in the expansion of the pharmaceutical contract packaging industry.

The globalization trend is anticipated to significantly influence the growth trajectory of the pharmaceutical contract packaging market. Globalization encompasses the interconnectedness of various aspects among nations, including economic, cultural, and technological exchanges. In the pharmaceutical industry, this trend prompts the need for standardized packaging solutions that adhere to diverse international regulations. Contract packaging providers play a crucial role in adapting pharmaceutical packaging to meet regional requirements and quality standards as global pharmaceutical supply chains expand. Reports from the United Nations Conference on Trade and Development highlight a significant surge in global trade values, reaching $28.5 trillion in 2021, indicating a 25% increase from 2020 and 13% higher than 2019. Thus, globalization is a driving force in the pharmaceutical contract packaging market.

Technological advancements stand out as a prominent trend shaping the pharmaceutical contract packaging market. Key industry players are prioritizing innovation to enhance their market presence. For instance, Gerresheimer AG and Stevanato Group introduced the EZ-fill Smart technology in November 2022. This platform integrates seamlessly with standard fill & finish operations, accommodating both small and large batch production while emphasizing improved drug packaging quality, reduced total cost of ownership (TCO), and expedited lead times. Additionally, it incorporates eco-friendly sterilization methods, biopolymers, and recycled plastics.

Strategic collaborations and partnerships are a significant strategy employed by major companies to fortify their positions in the pharmaceutical contract packaging market. Business alliances between enterprises are structured affiliations established through contractual agreements. In April 2021, Bushu Pharmaceuticals partnered with Suzuken, focusing on supporting new product launches for specialty pharmaceutical manufacturers entering the Japanese market. The collaboration extends to quality inspection, labeling, packaging, and distribution in Japan and the Asia-Pacific region. This strategic alliance aims to leverage shared expertise and expand market reach.

In December 2021, PCI Pharma Services, a prominent US-based entity specializing in pharmaceutical packaging services, completed the acquisition of Lyophilization Services of New England Inc. (LSNE), an England-based company renowned for its expertise in pharmaceutical contract packaging. The undisclosed deal aims to fortify PCI Pharma's portfolio, expanding their capabilities in pharmaceutical packaging, clinical trial supplies, and specialty production. This strategic move aligns with PCI Pharma's objective of enhancing their offerings and market presence within the pharmaceutical packaging sector.

Major companies operating in the pharmaceutical contract packaging market report are Nipro Corporation, Daito Pharmaceutical Co Ltd., Pfizer CentreOne, Catalent Inc., WestRock Company, BALL CORPORATION, Berlin Packaging, CCL Industries Inc., Co-Pak Packaging Corporation, Signode India Limited, Ropack Pharma Solutions, Reelvision Print Limited, PCI Pharma Services, Multi-Pack Solutions LLC, Unicep Packaging Inc., Reed-Lane Inc., Aphena Pharma Solutions Holdings Inc., Southwest Packaging and Supply Corporation, AbbVie Inc., Almac Group Limited, AmeriPac Inc., Assemblies Unlimited Inc., CentralPharma, DaklaPack Filling & Packaging, DelobrisPharmaceuticals Limited, Elitefill Inc., Finishing Services Inc., Jones Packaging Inc., LABO S.R.L., MJS Packaging Inc., MPH Co-Packing LLC, Nelipak B.V., Pharma Packaging Solutions LLC, Sepha Limited, SternMaid GmbH

North America was the largest region in the pharmaceutical contract packaging market in 2023. Asia-Pacific is expected to be the fastest-growing region in the pharmaceutical contract packaging market report during the forecast period. The regions covered in the pharmaceutical contract packaging market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pharmaceutical contract packaging market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The primary components of pharmaceutical contract packaging encompass primary, secondary, and tertiary packaging. Primary packaging directly interacts with the product and is often known as consumer or retail packaging. Utilizing materials like paper, paperboard, plastics, polymers, aluminum foil, glass, and other substances, primary packaging caters to small molecules, biopharmaceuticals, and vaccines, playing a crucial role in preserving and presenting pharmaceutical products.

This report provides pharmaceutical contract packaging market statistics, including pharmaceutical contract packaging industry global market size, regional shares, competitors with a pharmaceutical contract packaging market share, detailed pharmaceutical contract packaging market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical contract packaging industry. This pharmaceutical contract packaging market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pharmaceutical contract packaging market includes revenues earned by entities in different categories, such as drug labelling and packaging. The services provided by a contract pharmaceutical packager include designing medicine packaging and testing the packed drug. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.